Overview Nutraceutical on Hyperuricemia Status: Completed Trial end date: 2019-12-31 Target enrollment: Participant gender: Summary The aim of this study will be to evaluate if a nutraceutical containing quercetin, rutin, bromelain and L-carnosine (Uricemin®) can reduce uric acid levels in subjects with values between ≥ 6 and < 7 mg/dl after 3 months of therapy. Phase: Phase 4 Details Lead Sponsor: University of PaviaTreatments: Quercetin